CJC-1131

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCJC-1131
Drug Alias NameDAC:Glucagon-like peptide-1DAC:GLP-1CJC-1131
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConjuchem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConjuchem Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A